What amount sold does BIOMEDICAL VALUE FUND, L.P. report in Form D filings?

The latest linked filings report $674.1M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was BIOMEDICAL VALUE FUND, L.P.'s most recent SEC filing?

BIOMEDICAL VALUE FUND, L.P.'s most recent Form D filing was on 2025-12-17.

How many investors does BIOMEDICAL VALUE FUND, L.P. have?

The most recent Form D filing lists 93 investor(s).

BIOMEDICAL VALUE FUND, L.P.

CIK: 0001267460·Pooled Investment Fund·GREENWICH, CT·Limited Partnership

Reported Sold

$674,136,761

Total Filings

Identified Offerings

Last Filed

Dec 17, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Dec 17, 2025Form D/A — Amendment

Reported sold: $623,468,953 · Target: Indefinite

Rule 506(b)·93 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 18, 2024Form D/A — Amendment

Reported sold: $605,993,169 · Target: Indefinite

Rule 506(b)·114 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 19, 2023Form D/A — Amendment

Reported sold: $597,314,602 · Target: Indefinite

Rule 506(b)·116 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 23, 2022Form D/A — Amendment

Reported sold: $568,384,754 · Target: Indefinite

Rule 506(b)·103 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 20, 2021Form D/A — Amendment

Reported sold: $50,667,808 · Target: Indefinite

Rule 506(b)·98 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 20, 2021Form D — New notice

Reported sold: $549,293,586 · Target: Indefinite

Rule 506(b)·98 investors·Section 3(c), Section 3(c)(1)

Dec 17, 2020Form D/A — Amendment

Reported sold: $498,625,778 · Target: Indefinite

Rule 506(b)·118 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Feb 27, 2019Form D — New notice

Reported sold: $1,422,799 · Target: Indefinite

Rule 506(b)·4 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

75%

Latest reported sold across 2 identified offerings

$674,136,761

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jeffrey R. Jay

Executive Officer

Appears on 8 filings

-G

-- Great Point GP, LLC

Promoter

Appears on 6 filings

-G

-- Great Point Partners, LLC

Promoter

Appears on 6 filings

David Kroin

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 17, 2025	Amendment	Indefinite	$623,468,953	93
Dec 18, 2024	Amendment	Indefinite	$605,993,169	114
Dec 19, 2023	Amendment	Indefinite	$597,314,602	116
Dec 23, 2022	Amendment	Indefinite	$568,384,754	103
Dec 20, 2021	New	Indefinite	$549,293,586	98
Dec 20, 2021	Amendment	Indefinite	$50,667,808	98
Dec 17, 2020	Amendment	Indefinite	$498,625,778	118
Feb 27, 2019	New	Indefinite	$1,422,799	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ABS Direct Equity Fund LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 29, 2026